Editor's note: Every morning, James Altucher presents the most timely, topical posts from the Web's best business blogs. As always, let us know what you think.
really start this company?
13D Tracker writes, "BlueLine Partners
." I've been following this story for awhile. BlueLine, a hedge fund that looks like it specializes in medical device companies, has held 5% plus since the beginning of the year. I think this is an interesting situation.
First gold, then silver, then uranium. Now maybe it's time to look at
Phone.co -- er, I mean
Stock pick of the week
Russ Berrie and Company
down huge yesterday, Insight Asset Management has to figure out
with its short position.
Chris Anderson, author of
The Long Tail,
I always knew that
could translate into other activities.
The losers in the above contest should've
question No. 4.
Does this mean
. Will anyone buy my unlea.sh?
Michelle Leder at Footnoted.org always underlines this very well, but
Danny Sullivan, who normally writes at SearchEngineWatch blog, writes at clickz.com how the
is as strong as YouTube's growth.
At the time of publication, Altucher and/or his fund had no positions in any of the stocks mentioned, although positions may change at any time.
James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of
Trade Like a Hedge Fund
Trade Like Warren Buffett
. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;
to send him an email.
Interested in more writings from James Altucher? Check out his newsletter, TheStreet.com Internet Review. For more information,
TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.